Mouse Anti-DCTPP1 Recombinant Antibody (03) (V2LY-0125-LY1258)

Niu, M., Shan, M., Liu, Y., Song, Y., Han, J. G., Sun, S., ... & Zhang, G. Q. (2021). DCTPP1, an oncogene regulated by miR-378a-3p, promotes proliferation of breast cancer via DNA repair signaling pathway. Frontiers in oncology, 11, 723.

Mamoor, S. (2021). Differential expression of dCTP pyrophosphatase 1 in cancers of the breast.

Martínez-Arribas, B., Requena, C. E., Pérez-Moreno, G., Ruíz-Pérez, L. M., Vidal, A. E., & González-Pacanowska, D. (2020). DCTPP1 prevents a mutator phenotype through the modulation of dCTP, dTTP and dUTP pools. Cellular and Molecular Life Sciences, 77(8), 1645-1660.

Yue, Z., Shusheng, J., Hongtao, S., Shu, Z., Lan, H., Qingyuan, Z., ... & Yuanxi, H. (2020). Silencing DSCAM-AS1 suppresses the growth and invasion of ER-positive breast cancer cells by downregulating both DCTPP1 and QPRT. Aging (Albany NY), 12(14), 14754.

Friese, A., Kapoor, S., Schneidewind, T., Vidadala, S. R., Sardana, J., Brause, A., ... & Waldmann, H. (2019). Chemical genetics reveals a role of dCTP pyrophosphatase 1 in Wnt signaling. Angewandte Chemie, 131(37), 13143-13147.

Lu, J., Dong, W., He, H., Han, Z., Zhuo, Y., Mo, R., ... & Zhong, W. (2018). Autophagy induced by overexpression of DCTPP1 promotes tumor progression and predicts poor clinical outcome in prostate cancer. International journal of biological macromolecules, 118, 599-609.

Llona-Minguez, S., Hoglund, A., Wiita, E., Almlof, I., Mateus, A., Calderon-Montano, J. M., ... & Helleday, T. (2017). Identification of triazolothiadiazoles as potent inhibitors of the dCTP pyrophosphatase 1. Journal of Medicinal Chemistry, 60(5), 2148-2154.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols